|
Volumn 63, Issue 2, 2005, Pages 339-344
|
Novel molecular targeting therapeutics for prostate cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN II;
ANGIOTENSIN RECEPTOR ANTAGONIST;
CYTOKINE;
DNA BINDING PROTEIN;
G PROTEIN COUPLED RECEPTOR;
MITOGEN ACTIVATED PROTEIN KINASE;
STAT3 PROTEIN;
STAT3 PROTEIN, HUMAN;
TRANSACTIVATOR PROTEIN;
CELL DIVISION;
CHEMICAL PHENOMENA;
DRUG ANTAGONISM;
DRUG EFFECT;
HUMAN;
MALE;
METABOLISM;
PATHOLOGY;
PHOSPHORYLATION;
PHYSIOLOGY;
PROSTATE TUMOR;
QUALITY OF LIFE;
REVIEW;
SIGNAL TRANSDUCTION;
ANGIOTENSIN II;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
CELL DIVISION;
CYTOKINES;
DEPRESSION, CHEMICAL;
DNA-BINDING PROTEINS;
EXTRACELLULAR SIGNAL-REGULATED MAP KINASES;
HUMANS;
MALE;
PHOSPHORYLATION;
PROSTATIC NEOPLASMS;
QUALITY OF LIFE;
RECEPTORS, G-PROTEIN-COUPLED;
SIGNAL TRANSDUCTION;
STAT3 TRANSCRIPTION FACTOR;
TRANS-ACTIVATORS;
|
EID: 14944344708
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (2)
|